Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Realm Therapeutics, Inc. logo — company profile

Realm Therapeutics, Inc.

Founded 2006 United States Malvern, United States 2 employees Post-IPO Equity Total: $26.00M Biotechnology, Pharmaceutical

General Information

Company Name Realm Therapeutics, Inc.
Founded Year 2006
Location United States Malvern, United States
Employees 2
Industries Biotechnology, Pharmaceutical
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with Realm Therapeutics, Inc.. To contact Realm Therapeutics, Inc., visit realmtx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Realm Therapeutics, Inc. compare?

A PDF of Realm Therapeutics, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Realm Therapeutics, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Realm Therapeutics, Inc.

Realm Therapeutics is a clinical-stage biopharmaceutical company (AIM: RLM) focused on developing novel immunomodulatory therapies to protect and improve the lives of adults and children. The company has initiated drug development programmes, based on its proprietary hypochlorous acid technology at high concentrations. The Company believes its formulations have novel immunomodulatory activity with potential application for the treatment of diseases in a number of therapeutic areas, including Dermatology and Ophthalmology. Realm Therapeutics, founded in 2006 and headquartered in the United States, is advancing its immunomodulatory technology against inflammatory diseases with high unmet needs in Dermatology and Ophthalmology. The company has developed proprietary formulations of its novel technology for initial application in Atopic Dermatitis (PR022), Acne (PR023), and Allergic Conjunctivitis (PR013), as reflected in its pipeline chart at www.realmtx.com. The latest investment in Realm Therapeutics amounted to $26.00M in post-IPO equity, received on 22 September 2017. This investment came from notable venture capital firms including RA Capital Management, Abingworth, OrbiMed, BVF Partners, and Polar Capital. With its innovative technology and focus on unmet medical needs in Dermatology and Ophthalmology, Realm Therapeutics presents an appealing opportunity for investors looking to support groundbreaking developments in the biotechnology and pharmaceutical industries.

Business keywords: biopharmaceutical company, clinical-stage, immunomodulatory therapies, dermatology, ophthalmology, drug development, inflammatory diseases, hypochlorous acid technology, atopic dermatitis, acne, allergic conjunctivitis, proprietary formulations, small molecule therapies, developing novel therapies, high unmet medical needs

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity $26.00M 5
RA Capital Management Abingworth OrbiMed
RA Capital Management, Abingworth +3
22 Sep 2017

Realm Therapeutics, Inc. Alternatives & Competitors

View All Alternatives
Realm Therapeutics, Inc. vs
MatriSys Bioscience, Inc.
MatriSys Bioscience, Inc. United States

Harnessing beneficial bacteria to treat chronic inflammatory skin conditions.

Convertible Note
6 employees
Biopharma, Biotechnology
Realm Therapeutics, Inc. vs
AiViva Biopharma, Inc.
AiViva Biopharma, Inc. United States

Developing Novel, Localized Treatments in Oncology, Ophthalmology, Dermatology, and Urology to Trans...

16 employees
Biotechnology, Pharmaceutical
Realm Therapeutics, Inc. vs
GEn1E Lifesciences Inc.
GEn1E Lifesciences Inc. United States

Clinical-stage, Phase 2 company accelerating novel Precision Therapies for I&I and Rare Diseases usi...

Series A
18 employees
AI, Biotechnology
View all alternatives

FAQ About Realm Therapeutics, Inc.

Realm Therapeutics (AIM: RLM) is a clinical-stage biopharmaceutical company focused on developing novel immunomodulatory therapies to protect and improve the lives of adults and children. The Company has initiated drug development programmes, based on its proprietary hypochlorous acid technology at...
Realm Therapeutics, Inc. was founded in 2006.
Realm Therapeutics, Inc. is headquartered in Malvern, United States.
Realm Therapeutics, Inc. operates in Biotechnology and Pharmaceutical. Its work centres on biopharmaceutical company, clinical-stage, immunomodulatory therapies and dermatology.
Realm Therapeutics, Inc. has approximately 2 employees.
Realm Therapeutics, Inc. has completed 1 funding round, raising a total of $26.00M. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to Realm Therapeutics, Inc. include MatriSys Bioscience, Inc., AiViva Biopharma, Inc., GEn1E Lifesciences Inc., Ocuphire Pharma, Reviva Pharmaceuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Realm Therapeutics, Inc. and MatriSys Bioscience, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Realm Therapeutics, Inc., https://bouncewatch.com/company/realm-therapeutics, updated 17 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout